Implementation and Quality Monitoring of Stereotactic Body Radiotherapy for Spinal Metastases at the Institute of Oncology Ljubljana

What this Trial Is About

Researchers are evaluating stereotactic body radiotherapy SBRT, a precise, image-guided radiotherapy technique that delivers high-dose radiation in 1 to 5 sessions to treat spinal metastases and spinal tumors. This clinical program at the Institute of Oncology Ljubljana aims to support the structured use and ongoing development of the institutional SBRT spine protocol, focusing on treatment safety and tumor control. The study started after implementing SBRT in 2017 and introduced a standardized protocol in 2019 to maintain treatment quality and patient safety. Patients with spinal tumors or metastases receive SBRT following the institutional spine protocol, which includes standardized planning, immobilization, image-guided radiotherapy verification, and peer review of treatment plans. The program also involves regular educational workshops and quality assurance to ensure adherence to the protocol. Treatments are carefully planned and delivered with high precision to monitor outcomes continuously. Participants undergo routine clinical evaluations to assess treatment-related side effects using standardized criteria and to monitor local tumor control through regular radiological imaging. Data collected during the study are anonymized and involve no additional procedures beyond standard SBRT treatment and follow-up. The primary outcome is the maximum treatment-related adverse event grade within 12 months of SBRT, with ongoing monitoring of significant side effects and tumor control during this period.

SBRT Technique Implementation for Spinal Metastases Irradiation